Get started
RocketTickers

AbbVie Announces Positive Results from CLL14

Long
AbbVie Inc. (NYSE:ABBV)  
RocketTickers  
NYSE:ABBV   AbbVie Inc.
Beyond Technical Analysis
1
0
beyondta
ABBV: AbbVie
2018-10-31 16:14:00
AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic Leukemia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.